Active ingredient
Lanadelumab NDC Codes
Lanadelumab is an active ingredient in 2 finished products listed with the FDA, under 1 name.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Brand and generic names
- Takhzyro
- Strengths
- Lanadelumab 150 mg/mL; Lanadelumab 300 mg/2mL
- Dosage forms
- Solution
- Routes
- Subcutaneous
- Drug classes (FDA established)
- Plasma Kallikrein Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 2
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|
| Takhzyrolanadelumab-flyo | Lanadelumab 150 mg/mL | SolutionSubcutaneous | Takeda Pharmaceuticals America, Inc. | 47783-645 | 47783-0645-01 | — |
| Takhzyrolanadelumab-flyo | Lanadelumab 300 mg/2mL | SolutionSubcutaneous | Takeda Pharmaceuticals America, Inc. | 47783-646 | 47783-0646-01 | — |
Lanadelumab: common questions
- Which drugs contain Lanadelumab?
- Takhzyro.
- Is there a J-code for Lanadelumab?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.